|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 9/70 | |
| A61K 31/135 | |||
| A61K 47/02 |
| (11) | Patento numeris | 1731143 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 06011513.6 |
| Europos patento paraiškos padavimo data | 2006-06-02 | |
| (97) | Europos patento paraiškos paskelbimo data | 2006-12-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2008-11-26 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 2005165051 | 2005-06-06 | JP |
| (72) |
Inosaka, Keigo, JP
Muraoka, Takateru, JP
Iwao, Yoshihiro, JP
Takada, Akio, JP
Tsuda, Toshinobu, JP
Sekiya, Junichi, JP
|
| (73) |
NITTO DENKO CORPORATION,
1-2, Shimohozumi 1-chome Ibaraki-shi, Osaka,
JP
Fujimoto Co., Ltd., 3-40, Nishiotsuka 1-chome, Matsubara-shi, Osaka 580-0011, JP |
| (54) | Percutaneous absorption-type pharmaceutical preparation using a metal chloride, preferably sodium chloride, for preventing cohesive failure |
| Percutaneous absorption-type pharmaceutical preparation using a metal chloride, preferably sodium chloride, for preventing cohesive failure |